Clinics in Laboratory Medicine

Papers
(The median citation count of Clinics in Laboratory Medicine is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Copyright21
Taking Center Stage18
Forthcoming Issues18
Molecular Pathology18
Preanalytical Challenges of Molecular Microbiology Tests18
Forthcoming Issues16
Forthcoming Issues16
Contributors15
Contents15
Preface13
Contents13
Point of Care Testing13
Digital Health12
Pediatric Myelodysplastic Syndromes10
Hematopathology Gets Younger10
Updates in Blood Banking and Transfusion Medicine10
Bringing Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging to the Clinics10
Point of Care Molecular Testing9
The Role of Point-of-Care Testing in Specific Populations9
Replacement of Culture with Molecular Testing for Diagnosis Infectious Diseases8
Laboratory Testing and Health Disparities7
Current Topics in Molecular Diagnostics and Precision Medicine7
Promoting Health Equity Through Effective Laboratory Stewardship Strategies7
Contents7
Affirmative Healthcare for Transgender and Gender Nonconforming Patients7
Heparin Induced Thrombocytopenia Testing6
Copyright6
Advances in Clinical Cytometry6
Digital Imaging and AI Pre-classification in Hematology6
Literacy and Language Barriers to Overcome in Laboratory Medicine6
Treatment Considerations of Myelodysplastic Syndromes/Neoplasms for Pathologists5
Molecular Pathology of Ovarian Epithelial Neoplasms5
Pediatric Hemovigilance and Adverse Transfusion Reactions5
Rapid Antigen Assays for SARS-CoV-25
Premalignant Clonal Hematopoiesis (Clonal Hematopoiesis of Indeterminate Potential and Clonal Cytopenia of Undetermined Significance)5
Assessing Direct Oral Anticoagulants in the Clinical Laboratory5
Artificial Intelligence in the Clinical Laboratory5
Molecular Detection of Oncogenic Gene Rearrangements5
Cycle Threshold Values from Severe Acute Respiratory Syndrome Coronavirus-2 Reverse Transcription-Polymerase Chain Reaction Assays5
Update on Lymphoblastic Leukemia/Lymphoma5
Contents4
Molecular Oncology Diagnostics4
Molecular Pathology of Urothelial Carcinoma4
Hematology Laboratory in the Digital and Automation Age4
Suboptimal Humoral Immunity in Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Viral Variant Generation4
Copyright4
Contributors4
Utility of Single-Gene Testing in Cancer Specimens4
Copyright4
Glycan Imaging Mass Spectrometry4
Contributors4
Artificial Intelligence in the Clinical Laboratory: Current Practice and Emerging Opportunities4
Contributors4
Hemolytic Disease of the Fetus and Newborn4
Breaking Through the Barrier4
Forthcoming Issues4
Performance Evaluation of Lateral Flow Assays for Coronavirus Disease-19 Serology4
Contents4
Update on Ovarian Sex Cord–Stromal Tumors3
Is It Possible to Test for Viral Infectiousness?3
Copyright3
Point-of-Care Testing for the Diagnosis of Fungal Infections3
Contributors3
Flow Cytometry-based Immune Phenotyping of T and B Lymphocytes in the Evaluation of Immunodeficiency and Immune Dysregulation3
Significance of SF3B1 Mutations in Myeloid Neoplasms3
Diagnostic Stewardship for Multiplex Respiratory Testing3
Advances in Monitoring and Prognostication for Lymphoma by Flow Cytometry2
Infant Acute Leukemia2
Contributors2
Copy Number Analysis in Cancer Diagnostic Testing2
Will Antigen Testing Remain Relevant in the Point-of-Care Testing Environment?2
A Concise Synopsis of Current Literature and Guidelines on the Practice of Plasma Transfusion2
Forthcoming Issues2
Contributors2
Advances in Clinical Mass Cytometry2
Gene Rearrangement Detection in Pediatric Leukemia2
Copyright2
Utility of Flow Cytometry Analysis in the Detection of Nonhematologic Neoplasms2
Principles and Validation of Bioinformatics Pipeline for Cancer Next-Generation Sequencing2
Performance of Non-nasopharyngeal Sample Types for Molecular Detection of SARS-CoV-22
Transfusion Reactions and Adverse Events2
HLA Typing by Next-Generation Sequencing2
Breath-Based Diagnosis of Infectious Diseases1
The Report Says What?1
Topics in Pediatric Transfusion Medicine1
Severe Acute Respiratory Syndrome Coronavirus 2 Serology Testing – A Laboratory Primer1
Kidney Tumors1
Automation in Flow Cytometry1
Practical Challenges of Point-of-Care Testing1
Molecular Methods1
Opportunities and Challenges with Artificial Intelligence in Genomics1
Contents1
Utility of Fluorescence In Situ Hybridization in Clinical and Research Applications1
Antibody Dynamics and Durability in Coronavirus Disease-191
Flow Cytometric Assessment of Myelodysplastic Syndromes/Neoplasms1
Artificial Intelligence in the Clinical Laboratory1
Transfusion Medicine Informatics1
The Immunophenotypic Profile of Healthy Human Bone Marrow1
Advances and Progress in Automated Urine Analyzers1
Copyright1
Hematopathologic Correlates of CAR T-Cell Therapy1
Influence of Race Modifiers in Estimated Glomerular Filtration Rate Calculations on Medication Dosing, Access, and Transplant Eligibility1
Transfusion Support of Patients with Myelodysplastic Syndromes1
Contributors1
The Enduring and Expanding Importance of Clinical Cytometry1
Regulatory Approach to Point-of-Care/At-Home Testing in the United States1
Blood Product (Donor) Noninfectious and Infectious Testing and Modification1
Copyright1
The Medical Practice of Molecular Oncology Diagnostics1
Transfusion in Neonatal Patients1
Inclusive Laboratory Reference Intervals and Clinical Studies to Reduce Health Disparities1
Advances in Bone Marrow Evaluation1
Implementation of Mass Spectrometry Imaging in Pathology1
Diagnosis and Classification of Myelodysplastic Syndromes with Mutated TP531
Reactive Lymphadenopathies1
Molecular Pathology of Mature Lymphoid Malignancies1
Clinical Artificial Intelligence1
Contributors1
Hematopathology of the Young1
Role of Minimal Residual Disease Testing in Acute Myeloid Leukemia1
Present and Future Non-Culture-Based Diagnostics: Stewardship Potentials and Considerations1
Copyright1
Red Blood Cell Transfusion1
Applications of Noninvasive Prenatal Testing for Subchromosomal Copy Number Variations Using Cell-Free DNA0
The Successes and Challenges of SARS-CoV-2 Molecular Testing in the United States0
Perspectives on Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 and Its Implications for Diagnostics, Biology, and Clinical Management0
Screening of Myelodysplastic Syndromes Using Research Parameters of Complete Blood Count0
Specimen Considerations in Molecular Oncology Testing0
Current Topics in Molecular Diagnostics and Precision Medicine0
Update on Acute Leukemias of Ambiguous Lineage0
Molecular Pathology of Lung Cancer0
The Evolving Role of Molecular Diagnostics in Pathology0
Severe Acute Respiratory Syndrome Coronavirus 2 Antigens as Targets of Antibody Responses0
Copyright0
Laboratory Aspects of Minimal / Measurable Residual Disease Testing in B-Lymphoblastic Leukemia0
Precision Medicine Using Pharmacogenomic Panel-Testing0
Next-Generation Sequencing Approaches to Predicting Antimicrobial Susceptibility Testing Results0
Inventory Management and Product Selection in Pediatric Blood Banking0
Molecular Pathology of Gliomas0
How to Design and Validate a Clinical Flow Cytometry Assay0
Pediatric Myeloproliferative Neoplasms0
Myelodysplastic Syndromes0
Best Practice for Clinical Somatic Variant Interpretation and Reporting0
Transfusion in Pediatric Patients0
Artificial Intelligence in the Genetic Diagnosis of Rare Disease0
Contents0
Panel Sequencing for Targeted Therapy Selection in Solid Tumors0
Forthcoming Issues0
Analytic and Clinical Performance of Major Commercial Severe Acute Respiratory Syndrome Coronavirus 2 Molecular Assays in the United States0
Hematology Laboratory in the Digital and Automation Age0
Metaplastic Breast Carcinoma Revisited; Subtypes Determine Outcomes0
Contents0
Using Artificial Intelligence to Better Predict and Develop Biomarkers0
Opportunities and Drawbacks of Digitalized Morphologic Analysis of Body Fluids0
Alternative Methods to Detect Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies0
Access Barriers in Testing for Sexually Transmitted Infections across Gender and Sexual Identities0
Donor Screening and Deferral0
Strategies for Scaling up SARS-CoV-2 Molecular Testing Capacity0
An Overview of SARS-CoV-2 Molecular Diagnostics in Europe0
Forthcoming Issues0
Building Evidence for Clinical Use of Pharmacogenomics and Reimbursement for Testing0
A New Landscape of Testing and Therapeutics in Metastatic Breast Cancer0
Artificial Intelligence Applications in Clinical Chemistry0
Contributors0
Childhood Myelodysplastic Syndrome0
Advances in Myelodysplastic Syndromes0
Addressing Health Disparities in Clinical Pathology and Laboratory Medicine0
The Development of the Nascent Field of Pediatric Transfusion Medicine0
Nothing Basic About It: Guiding the Judicious Use of Diagnostic Tests0
Molecular Biomarkers of Response to Cancer Immunotherapy0
Transfusion and Cellular Therapy in Pediatric Sickle Cell Disease0
Platelet Transfusion0
Molecular Techniques and Gene Mutations in Myelodysplastic Syndromes0
Pan-Cancer Molecular Biomarkers0
Matrix-Assisted Laser Desorption Ionization Time-of-Flight for Fungal Identification0
Molecular Pathology of Breast Tumors0
Copyright0
Electronic Health Record Optimization for Artificial Intelligence0
Forthcoming Issues0
Flow Cytometry in Diagnosis, Prognostication, and Monitoring of Multiple Myeloma and Related Disorders0
Contributors0
Molecular Alterations in Pediatric Solid Tumors0
Clinical Mass Spectrometry Approaches to Myeloma and Amyloidosis0
Forthcoming Issues0
A Review of the Flow Cytometric Findings in Classic Hodgkin Lymphoma, Nodular Lymphocyte Predominant Hodgkin Lymphoma and T Cell/Histiocyte-Rich Large B Cell Lymphoma0
Contributors0
Forthcoming Issues0
Flow Cytometric Assessment of Malignant Hematologic Disorders0
Advances in Hematology Analyzers Technology0
Whole Blood Transfusion0
Updates in Blood Banking and Transfusion Medicine0
Home and Clinical Laboratory Improvement Amendments–Waived Testing for Infectious Diseases—How Do These Fit in the Testing Landscape?0
Contents0
Contributors0
Diagnostic Stewardship for Next-Generation Sequencing Assays in Clinical Microbiology0
Forthcoming Issues0
Covid-19 Molecular Testing and Clinical Correlates0
Contributors0
Steps Forward to a Fair and Inclusive Blood Supply0
Antigen Loss after Targeted Immunotherapy in Hematological Malignancies0
Contents0
A Tale of Trial and Triumph: Molecular Diagnostics for Severe Acute Respiratory Coronavirus 2 Over the First Two Years of the Coronavirus Disease 2019 Pandemic0
Vaccine-Induced Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and the Path to Accelerating Development (Determining a Correlate of Protection)0
Contributors0
Molecular Diagnostic Testing for Hematopoietic Neoplasms0
Advances in Hemoglobinopathies and Thalassemia Evaluation0
Working with the Electronic Health Record and Laboratory Information System to Maximize Ordering and Reporting of Molecular Microbiology Results0
The Hematological Differential Diagnosis of Mediastinal Masses0
Diagnostics Stewardship in Molecular Microbiology: From at-home Testing to Next-Generation Sequencing0
Clinical Diagnostic Point-of-Care Molecular Assays for SARS-CoV-20
Molecular Pathology of Gastroesophageal Cancer0
Morphologic Characteristics of Myelodysplastic Syndromes0
Beyond LC-MS: The Next Frontier in Clinical Mass Spectrometry0
Transfusion Blood Bank (Recipient) Testing0
Performance Characteristics of High-Throughput Serologic Assays for Severe Acute Respiratory Syndrome Coronavirus 2 with Food and Drug Administration Emergency Use Authorization0
Advances in Acute Myeloid Leukemia Classification, Prognostication and Monitoring by Flow Cytometry0
Laboratory Aspects of Minimal / Measurable Residual Disease Testing in B-Lymphoblastic Leukemia0
Contents0
Germline Predisposition to Myeloid Neoplasms0
Forthcoming Issues0
Analytical Principles of Cancer Next Generation Sequencing0
Novel Blood Component Therapies in the Pediatric Setting0
Blood Group Genotyping0
Forthcoming Issues0
Evolving Approach to Clinical Cytometry for Immunodeficiencies and Other Immune Disorders0
Molecular Pathology of Myeloid Neoplasms0
Molecular Pathology of Prostate Cancer0
Copyright0
Forthcoming Issues0
Applications of Flow Cytometry in Diagnosis and Evaluation of Red Blood Cell Disorders0
Evaluation and Management of Coagulopathies and Thrombophilias in Pediatric Patients0
Cell-free Nucleic Acids in Cancer0
Point-of-Care Testing for Sexually Transmitted Infections0
Mass Spectrometry and Microbial Diagnostics in the Clinical Laboratory0
Special Considerations in the Molecular Diagnostics of Pediatric Neoplasms0
Molecular Genetics of Pediatric Acute Myeloid Leukemia0
Routine Coagulation0
Copyright0
Contributors0
Contents0
History, Advances, and Challenges of Sickle Cell Disease Treatment0
Mass Cytometry, Imaging Mass Cytometry, and Multiplexed Ion Beam Imaging Use in a Clinical Setting0
Clinical Cytometry for Platelets and Platelet Disorders0
Update on Pediatric and Young Adult Mature Lymphomas0
Approaches to Deployment of Molecular Testing for SARS-CoV-2 in Resource-Limited Settings0
Racism in Drug Testing0
Massive Transfusion in Pediatric Patients0
Syndromic and Point-of-Care Molecular Testing0
SARS-CoV-2 Molecular Diagnostics in China0
Forthcoming Issues0
0.09959602355957